News & Views

Cancer health disparities

Nurses Address Barriers to Care Through CoC’s Revised Standards

Many factors can affect the way patients access their care. But one thing is certain: if patients don’t get the care they need, their chances for success decline. To address barriers to cancer care, the American College of Surgeons’ Commission on Cancer (CoC) outlined specific, measurable actions that institutions must take.

Trending Topics

View All Topics

FDA Grants Accelerated Approval to Capmatinib for Metastatic Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Capmatinib for Metastatic Non-Small Cell Lung Cancer

Meet Your ONS Leader: Marty Polovich, PhD, RN

Meet Your ONS Leader: Marty Polovich, PhD, RN

Remodeled CAR T-Cell Therapy May Reduce Side Effects

Cancer treatments

Remodeled CAR T-Cell Therapy May Reduce Side Effects

Harnessing the Abscopal Effect May Change Cancer Care

Radiation therapy

Harnessing the Abscopal Effect May Change Cancer Care

The Next Frontier for Oncology Nursing Care

Combination Immunotherapy

FDA Approves Daratumumab and Hyaluronidase-Fihj for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Daratumumab and Hyaluronidase-Fihj for Multiple Myeloma

Nursing Innovation, Leadership, and Dedication Shine During Pandemic

Nursing Innovation, Leadership, and Dedication Shine During Pandemic

Unique Roles in Oncology Nursing: Oncology Nurse Navigation

Nurse navigator

Unique Roles in Oncology Nursing: Oncology Nurse Navigation

FDA Approves New Dosing Regimen for Pembrolizumab

U.S. Food and Drug Administration (FDA)

FDA Approves New Dosing Regimen for Pembrolizumab

FDA Approves Niraparib for First-Line Maintenance of Advanced Ovarian Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Niraparib for First-Line Maintenance of Advanced Ovarian Cancer

The Evidence for Herbal Supplements for Immunity and Stress During COVID-19

The Evidence for Herbal Supplements for Immunity and Stress During COVID-19

Oncology Drug Reference Sheet: Daratumumab

Oncology drug research

Oncology Drug Reference Sheet: Daratumumab

Meet Your ONS Leader: Heather Thompson Mackey, MSN, ANP-BC, AOCN®

Meet Your ONS Leader: Heather Thompson Mackey, MSN, ANP-BC, AOCN®

FDA Grants Accelerated Approval to Sacituzumab Govitecan-Hziy for Metastatic Triple-Negative Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Sacituzumab Govitecan-Hziy for Metastatic Triple-Negative Breast Cancer

FDA Announces Leucovorin Drug Shortage

U.S. Food and Drug Administration (FDA)

FDA Announces Leucovorin Drug Shortage

FDA Approves Ibrutinib Plus Rituximab for Chronic Lymphocytic Leukemia

U.S. Food and Drug Administration (FDA)

FDA Approves Ibrutinib Plus Rituximab for Chronic Lymphocytic Leukemia

Drug Combo May Be Effective for BRCA-Mutated Pancreatic Cancer

Pancreatic cancer

Drug Combo May Be Effective for BRCA-Mutated Pancreatic Cancer

Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

Cancer screening

Oral and Oropharyngeal Cancer Prevention, Screening, Treatment, and Survivorship Recommendations

FDA Approves First Targeted Treatment for Patients With Cancer of Bile Ducts

U.S. Food and Drug Administration (FDA)

FDA Approves First Targeted Treatment for Patients With Cancer of Bile Ducts

FDA Approves First New Drug Under International Collaboration, a Treatment Option for Patients With HER2-Positive Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves First New Drug Under International Collaboration, a Treatment Option for Patients With HER2-Positive Metastatic Breast Cancer 

International Position Statement Calls for Advocacy for COVID-19 in Oncology Nurses and Patients With Cancer

Cancer healthcare advocacy

International Position Statement Calls for Advocacy for COVID-19 in Oncology Nurses and Patients With Cancer

FDA Approves Mitomycin for Low-Grade, Upper-Tract Urothelial Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Mitomycin for Low-Grade, Upper-Tract Urothelial Cancer 

New Treatments Show Promise for Metastatic HER2-Positive Breast Cancer

New Treatments Show Promise for Metastatic HER2-Positive Breast Cancer

Oncology Drug Reference Sheet: Tocilizumab (Actemra®)

Oncology Drug Reference Sheet: Tocilizumab

The Case of the Cryotherapy Consequences

Cancer treatments

The Case of the Cryotherapy Consequences

Palliative Care Resources Comfort Nurses Through COVID-19 Stress, Dilemmas, and Grief

Palliative Care Resources Comfort Nurses Through COVID-19 Stress, Dilemmas, and Grief

FDA Approves Encorafenib in Combination With Cetuximab for Metastatic Colorectal Cancer With a BRAF V600E Mutation

U.S. Food and Drug Administration (FDA)

FDA Approves Encorafenib in Combination With Cetuximab for Metastatic Colorectal Cancer With a BRAF V600E Mutation

Manage Thrombosis in Patients With Cancer

Symptom management

Manage Thrombosis in Patients With Cancer

Global Cancer Cases Could Increase 60% in Next 20 Years

Cancer prevention

Global Cancer Cases Could Increase 60% in Next 20 Years

Cope With COVID-19 Through Mind-Body Therapies for Oncology Nurses

Nurse self-care

Cope With COVID-19 Through Mind-Body Therapies for Oncology Nurses

What the Evidence Says About Acupuncture and Cognitive-Behavioral Therapy for Insomnia

Complementary therapy

What the Evidence Says About Acupuncture and Cognitive-Behavioral Therapy for Insomnia

FDA Approves Luspatercept-Aamt for Anemia in Adults With MDS

U.S. Food and Drug Administration (FDA)

FDA Approves Luspatercept-Aamt for Anemia in Adults With MDS 

Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says

Prevent a Global Nursing Shortage by Investing in Nursing’s Future, WHO Says

Prevent, Recognize, and Manage Sepsis in Patients With Cancer

Cancer prevention

Prevent, Recognize, and Manage Sepsis in Patients With Cancer

Geographic Disparities Affect Clinical Trials Participation for Minorities

Cancer health disparities

Geographic Disparities Affect Clinical Trials Participation for Minorities

FDA Requests Withdrawal of All Ranitidine Products

U.S. Food and Drug Administration (FDA)

FDA Requests Withdrawal of All Ranitidine Products

New Nursing Research Sheds Light on Chemotherapy Safety

New Nursing Research Sheds Light on Chemotherapy Safety

A Zip Code Doesn’t Tell the Whole Story

Cancer health disparities

Geographic Disparities in Cancer Care

FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer

Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk

Genomic Classifier Predicts Breast Cancer Radiation Benefit, Recurrence Risk

Latinas’ Breast Cancer Genetic Disparities Require More Focused Counseling and Testing

Latinas’ Breast Cancer Genetic Disparities Require More Focused Counseling and Testing

Leaders Shape You, and as a Leader, You Influence Others, Too

Leaders Shape You, and as a Leader, You Influence Others, Too

ONS Sets Health Policy Agenda for 116th U.S. Congress

ONS Sets Health Policy Agenda for 116th U.S. Congress

Prostate Cancer Disparities Disappear With Equal Access to Care

Cancer health disparities

Prostate Cancer Disparities Disappear With Equal Access to Care

Nurses Are Critical to Reducing Global Geographic Cancer Disparities

Cancer health disparities

Nurses Are Critical to Reducing Global Geographic Cancer Disparities

Healthcare Industry Relies on Public Amid COVID-19 PPE Supply Shortage

Healthcare Industry Looks to Public Amid COVID-19 PPE Supply Shortage

What Happens During a Genetics Counseling Session?

Genetics & genomics

What Happens During a Genetics Counseling Session?

Meet Your ONS Leader: Anne M. Ireland, MSN, RN, AOCN®, CENP

Meet Your ONS Leader: Anne M. Ireland, MSN, RN, AOCN®, CENP

FDA Issues Guidance for Conducting Clinical Trials During COVID-19

U.S. Food and Drug Administration (FDA)

FDA Issues Guidance for Conducting Clinical Trials During COVID-19

Back to Top ▲